These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Lipoprotein(a) in the nephrotic syndrome: molecular analysis of lipoprotein(a) and apolipoprotein(a) fragments in plasma and urine. Doucet C; Mooser V; Gonbert S; Raymond F; Chapman J; Jacobs C; Thillet J J Am Soc Nephrol; 2000 Mar; 11(3):507-513. PubMed ID: 10703674 [TBL] [Abstract][Full Text] [Related]
9. High plasma levels of apo(a) fragments in Caucasians and African-Americans with end-stage renal disease: implications for plasma Lp(a) assay. Mooser V; Marcovina SM; Wang J; Hobbs HH Clin Genet; 1997 Nov; 52(5):387-92. PubMed ID: 9520131 [TBL] [Abstract][Full Text] [Related]
10. Decreased urinary apolipoprotein (a) excretion in patients with impaired renal function. Kostner KM; Clodi M; Bodlaj G; Watschinger B; Hörl W; Derfler K; Huber K Eur J Clin Invest; 1998 Jun; 28(6):447-52. PubMed ID: 9693935 [TBL] [Abstract][Full Text] [Related]
11. Elevated lipoprotein(a) levels and small apo(a) isoforms are compatible with longevity: evidence from a large population of French centenarians. Thillet J; Doucet C; Chapman J; Herbeth B; Cohen D; Faure-Delanef L Atherosclerosis; 1998 Feb; 136(2):389-94. PubMed ID: 9543111 [TBL] [Abstract][Full Text] [Related]
12. Apo(a)-isoform size, nutritional status and inflammatory markers in chronic renal failure. Stenvinkel P; Heimbürger O; Tuck CH; Berglund L Kidney Int; 1998 May; 53(5):1336-42. PubMed ID: 9573549 [TBL] [Abstract][Full Text] [Related]
13. Heterozygous apolipoprotein (a) status and protein expression as a risk factor for premature coronary heart disease. Martín S; Pedro-Botet J; Joven J; Simó JM; Ladona MG; Pavesi M; Rubiés-Prat J J Lab Clin Med; 2002 Mar; 139(3):181-7. PubMed ID: 11944029 [TBL] [Abstract][Full Text] [Related]
15. Lipoprotein (a) levels and apolipoprotein (a) isoform size in patients with subclinical hypothyroidism: effect of treatment with levothyroxine. Milionis HJ; Efstathiadou Z; Tselepis AD; Bairaktari ET; Tsironis LD; Tsatsoulis A; Elisaf MS Thyroid; 2003 Apr; 13(4):365-9. PubMed ID: 12804105 [TBL] [Abstract][Full Text] [Related]
16. Associations among serum lipoprotein(a) levels, apolipoprotein(a) phenotypes, and myocardial infarction in patients with extremely low and high levels of serum lipoprotein(a). Saku K; Zhang B; Liu R; Shirai K; Arakawa K Jpn Circ J; 1999 Sep; 63(9):659-65. PubMed ID: 10496479 [TBL] [Abstract][Full Text] [Related]
17. Influence of lipoprotein (a) levels and isoforms on fibrinolytic activity--study in families with high lipoprotein (a) levels. Falcó C; Estellés A; Dalmau J; España F; Aznar J Thromb Haemost; 1998 Apr; 79(4):818-23. PubMed ID: 9580386 [TBL] [Abstract][Full Text] [Related]
18. A prospective case-control study of lipoprotein(a) levels and apo(a) size and risk of coronary heart disease in Stanford Five-City Project participants. Wild SH; Fortmann SP; Marcovina SM Arterioscler Thromb Vasc Biol; 1997 Feb; 17(2):239-45. PubMed ID: 9081676 [TBL] [Abstract][Full Text] [Related]
19. Serum lipids, lipoprotein(a) and apo(a) isoforms in patients with established coronary artery disease and their relation to disease and prognosis after coronary by-pass surgery. Lindén T; Taddei-Peters W; Wilhelmsen L; Herlitz J; Karlsson T; Ullström C; Wiklund O Atherosclerosis; 1998 Mar; 137(1):175-86. PubMed ID: 9568750 [TBL] [Abstract][Full Text] [Related]
20. Association of lipoprotein(a) concentration and apo(a) isoform size with restenosis after percutaneous transluminal coronary angioplasty. Sirikci O; Aytekin V; Demiroglu IC; Demiroglu C; Marcovina SM Int J Clin Lab Res; 2000; 30(2):93-9. PubMed ID: 11043503 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]